We have also discovered, for the first time, that c‐Fos can be used as an indicator of the sensitivity of HDACi, and the combination of LAQ824 and c‐Fos inhibitors synergistically killed DLBCL cells in vitro and in vivo. This evidence concerns the gene FOS and diffuse large B-cell lymphoma.